Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Tuberculosis and UGT1A1[original query] |
---|
UGT1A1 polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012 16 (3): 376-8. Chang J-C, Liu E H, Lee C-N, Lin Y-C, Yu M-C, Bai K-J, Chen H |
CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016 Jun 20 (6): 812-8. Chen R, Wang J, Tang S-W, Zhang Y, Lv X-Z, Wu S-S, Yang Z-R, Xia Y-Y, Chen D-F, Zhan S |
Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study. Clinical drug investigation 2017 Sep . Sun Qin, Liu Hai-Peng, Zheng Rui-Juan, Wang Peng, Liu Zhi-Bin, Sha Wei, Xiao He-Pi |
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial agents and chemotherapy 2023 10 e0043023. Allan Kengo, Ruth Nabisere, Kamunkhwala Gausi, Joseph Musaazi, Allan Buzibye, Denis Omali, Rob Aarnoutse, Mohammed Lamorde, Kelly E Dooley, Derek James Sloan, Paolo Denti, Christine Sekaggya-Wiltshi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: